Phenotype of striatal cells expressing c-Fos following amphetamine treatment of rats with intrastriatal dopaminergic grafts

European Journal of Neuroscience

Volumn 8, Issue 12, 1996, Pages 2521-2529

  Abrous, D N ^a   Bernard, V ^b   Le Moal, M ^a   Bloch, B ^b   Herman, J P ^c  

^a INSERM   (France)

^b CNRS   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Dopaminergic grafts; Efferent striatal system; Fos; Immunohistochemistry; In situ hybridization; Mesotelencephalic pathway; Neostriatum; Rat

Indexed keywords

AMPHETAMINE; ENKEPHALIN; NEUROPEPTIDE Y; OXIDOPAMINE; PREPROENKEPHALIN; PROTEIN C FOS; PSYCHOSTIMULANT AGENT; SUBSTANCE P;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CELL; BRAIN GRAFT; BRAIN INJURY; CELL DENSITY; CELL POPULATION; CELL TRANSPLANTATION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GENE ACTIVATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE GRAFT; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORY NERVE; STRIATE CORTEX;

AMPHETAMINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; NERVE TISSUE; NEURONS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR; TYROSINE 3-MONOOXYGENASE;

EID: 0030466646     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.1996.tb01546.x     Document Type: Article

References (46)

1. Abrous, D. N., Torres, E. M., Annett, L. E., Reading, P. and Dunnett, S. B. (1992) Intrastriatal dopaminergic-rich grafts induce a hyperexpression of Fos protein when challenged with amphetamine. Exp. Brain Res., 91, 181-190.
2. Abrous, D. N., Manier, M., Mennicken, F., Feuerstein, C., Le Moal, M. and Herman, J. P. (1993) Intrastriatal transplants of embryonic dopaminergic neurons counteract the increase of striatal enkephalin immunostaining but not serotoninergic sprouting elicited by a neonatal lesion of the nigrostriatal dopaminergic pathway. Eur. J. Neurosci., 5, 128-136.
3. Abrous, D. N., Le Moal, M. and Herman, J. P. (1994) Dopaminergic neurones implanted to neonates reverse the increase of neuropeptide Y induced in the neostriatum by the unilateral lesion of the dopaminergic system made in infancy. Brain Res., 656, 169-173.
4. Abrous, D. N., Desjardins, S., Sorin, B., Le Moal, M. and Herman, J. P. (1996) Changes in striatal immediate-early gene expression following neonatal dopaminergic lesion and effects of intrastriatal dopaminergic transplants. Neuroscience, 73, 145-159.
5. Alexander, G. E. and Crutcher, M. D. (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci., 13, 266-271.
6. Bal, A., Savasta, M., Chritin, M., Mennicken, F., Abrous, D. N., Le Moal, M., Feuerstein, C. and Herman, J. P. (1993) Transplantation of fetal nigral cells reverses the increase of preproenkephalin mRNA levels in the rat striatum caused by 6-OHDA lesion of the dopaminergic nigrostriatal pathway: a quantitative in situ hybridization study. Mol. Brain Res., 18, 221-227.
7. Bhat, R. and Baraban, J. M. (1993) Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J. Exp. Pharmacol. Exp. Ther., 267, 496-505.
8. Bernard, V., Normand, E. and Bloch, B. (1992) Phenotopical characterization of the rat striatal neurons expressing muscarinic receptor genes. J. Neurosci., 12, 3591-3600.
9. Bernard, V., Dumartin, B., Lamy, E. and Bloch, B. (1993) Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in rat. Eur. J. Neurosci., 5, 1218-1225.
10. Cenci, M. A., Campbell, K., Wictorin, K. and Björklund, A. (1992a) Striatal c-fos induction by cocaine of apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat. Eur. J. Neurosci., 4, 376-380.
11. Cenci, M. A., Kalen, P., Mandel, R. J., Wictorin, K. and Björklund, A. (1992b) Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Neuroscience, 46, 943-958.
12. Cenci, M. A., Campbell, K. and Björklund, A. (1993) Neuropeptide-mRNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects on preproenkephalin-, preprotachychinin-, and prodynorphin-mRNA levels. Neuroscience, 57, 275-296.
13. Cenci, M. A. and Björklund, A. (1994) Transection of cortico-striatal afferents abolishes the hyperexpression of Fos and counteracts the development of rotational overcompensation induced by intrastriatal dopamine-rich graft when challenged with amphetamine. Brain Res., 665, 167-174.
14. Chesselet, M.-F. (1984) Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Neuroscience, 12, 347-375.
15. Chritin, M., Savasta, M., Mennicken, F., Bal, A., Abrous, D. N., Le Moal, M., Feuerstein, C. and Herman, J. P. (1992) Intrastriatal dopamine-rich implants reverse the increase of dopamine D2 receptor mRNA levels caused by lesion of the nigrostriatal pathway: a quantitative in situ hybridization study. Eur. J. Neurosci., 4, 663-672.
16. Corder, R. and Lowry, P. J. (1985) An immunoradiometric assay for the measurement of neuropeptide Y in plasma. Peptides, 6, 1195-1200.
17. Fénu, S., Carta, A. and Morelli, M. (1995) Modulation of dopamine D1-mediated turning behavior and striatal c-fos expression by the substantia nigra. Synapse, 19, 223-240.
18. Freund, T. F., Bolam, J. P., Björklund, A., Stenevi, U., Dunnett, S. B., Powell, J. F. and Smith, J. D. (1985) Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J. Neurosci., 5, 603-616.
19. Graybiel, A. M., Moratalla, R. and Robertson, H. A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl Acad. Sci. USA, 87, 6912-6916.
20. Herera-Marschitz, M. and Ungerstedt, U. (1984) Evidence of striatal efferents relate to different dopamine receptors. Brain Res., 323, 269-278.
21. Herman, J. P., Choulli, K. and Le Moal, M. (1985) Hyper-reactivity to amphetamine in rats with dopaminergic grafts. Exp. Brain Res., 60, 521-526.
22. Herman, J. P., Lupp, A., Abrous, N., Le Moal, M., Hertting, G. and Jackisch, R. (1988) Intrastriatal dopaminergic grafts restore inhibitory control over striatal cholinergic neurons. Exp. Brain Res., 73, 236-248.
23. Herman, J. P., Rougé-Pont, F., Le Moal, M. and Abrous, D. N. (1993) Mechanisms of amphetamine-induced rotation in rats with unilateral intrastriatal grafts of embryonic dopaminergic neurons: a pharmacological and biochemical analysis. Neuroscience, 53, 1083-1095.
24. Herman, J. P. and Abrous, D. N. (1994) Dopaminergic neural grafts after fifteen years: results and perspectives. Prog. Neurobiol., 44, 1-35.
25. 1 receptor with adenylyl cyclase. J. Neurosci., 13, 2237-2248.
26. Hughes, P. and Dragunow, M. (1995) Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev., 47, 133-178.
27. Jaber, M., Cador, M., Dumartin, B., Normand, E., Stinus, L. and Bloch, B. (1995) Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience, 65, 1041-1050.
28. Johansson, B., Lindström, K. and Fredholm, B. B. (1994) Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience, 59, 837-849.
29. Lucas, J. J., Koester, J. and Hen, R. (1995) Mice lacking 5-HT1B receptors display a reduced effect of cocaine on striatal c-Fos immunoreactivity. Soc. Neurosci. Abstr., 21, 287.2.
30. Manier, M., Abrous, D. N., Feuerstein, C., Le Moal, M. and Herman, J. P. (1991) Increase of striatal methionin enkephalin content following lesion of the nigrostriatal dopaminergic pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurons: a quantitative immunohistochemical analysis. Neuroscience, 42, 427-439.
31. Mennicken, F., Savasta, M., Feuerstein, C., Le Moal, M., Herman, J. P. and Abrous, D. N. (1995) The neonatal lesion of the dopaminergic mesotelencephalic dopaminergic pathway increases intrastriatal D2 receptor levels and synthesis and this effect is reversed by neonatal dopaminergic rich-graft. Mol. Brain Res., 28, 211-221.
32. Miller, R. and Beninger, R. J. (1991) On the interpretation of asymmetries of posture and locomotion produced with dopamine agonists in animals with unilateral depletion of striatal dopamine. Progress Neurobiol., 36, 229-256.
33. Mogenson, G. J. and Yang, C. R. (1987) Dopamine modulation of limbic and cortical inputs to striatal neurons. In Chiodo, L. A. and Freeman, A. S. (eds), Neurophysiology of Dopaminergic Systems - Current Status and Clinical Perspectives. Lakeshore Publishing Company, Detroit, MI, pp. 237-251.
34. Moukhles, H., Nioullon, A. and Daszuta, A. (1992) Early and widespread normalization of dopamine-neuropeptide Y interactions in the rat striatum after transplantation of fetal mesencephalon cells. Neuroscience, 47, 781-792.
35. Morelli, M., Fénu, S., Cozzolino, A., Pinna, A., Carta, A. and Di Chiara, G. (1993) Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses. Neuroscience, 53, 673-678.
36. 2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci., 12, 3729-3742.
37. Pellegrino, L. J., Pellegrino, A. S. and Cushman, A. J. (1967) A Stereotaxic Atlas of the Rat Brain. Plenum Press, New York.
38. Roy, E., Côté, P. Y., Parent, A. and Bedard, P. J. (1995) Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine. Neuroscience, 66, 413-425.
39. 2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study. Neuroscience, 46, 729-738.
40. Segovia, J., Meloni, R. and Gale, K. (1989) Effect of dopaminergic denervation and transplant-derived reinnervation on a marker of striatal GABAergic function. Brain Res., 493, 185-189.
41. +): reversal by embryonic nigral dopamine grafts. Mol. Brain Res., 9, 263-269.
42. Soubrié, P., Reisine, T. D. and Glowinski, J. (1984) Functional aspects of serotonin transmission in the basal ganglia: a review and in vivo approach using the push-pull cannula technique. J. Neurosci., 13, 605-625.
43. Starr, M. S. (1995) Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse, 19, 264-293.
44. Strecker, R. E., Sharp, T., Brundin, P., Zetterstöm, T., Ungerstedt, U. and Björklund, A. (1987) Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intrastriatal dialysis. Neuroscience, 22, 169-178.
45. Young, S. T., Porrino, L. J. and Iadarola, M. J. (1991) Cocaine induces striatal c-Fos immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl Acad. Sci. USA, 88, 1291-1295.
46. Zhang, W. Q., Pennypacker, K. R., Merchenthaler, J. J., Grimes, L., Iadorola, M. J. and Hong, J. S. (1992) A 35 kDA Fos related antigen is co-localized with substance P and dynorphin in striatal neurones. Brain Res., 577, 312-317.